Condition: Coronary Arterial Disease (CAD) · Sponsor: Kutahya Health Sciences University
Coronary stents are the best treatment method ever accepted in the treatment of coronary artery stenoses. Due to some limitations and complications of stent use, the operators tried to find new solutions. Drug Coated Balloons (DCBs) have been accepted as a new method in the treatment of in-stent restenosis and small vessel disease. Furthermore, they have been used in the treatment of de novo coronary lesions, chronic total occlusions and bifucation lesions. But data is limited in the short and long term success of DCBs in all these clinical scenarios. In our study we aimed to investigate the procedural success and short and long term outcomes of DCB use in different clinical scenarios.
This description comes directly from the study's public registry record.
Fatih Kahraman, Associate Professor · +905442764616 · fatih.kahraman@ksbu.edu.tr
Always discuss trial participation with your own doctor first.
| Pamukkale University | Denizli, Turkey (Türkiye) | Recruiting |
| Bahcelievler Memorial Hospital | Istanbul, Turkey (Türkiye) | Recruiting |
| Bezmialem Vakıf Universitesi | Istanbul, Turkey (Türkiye) | Recruiting |
| Goztepe Medicalpark Hastanesi | Istanbul, Turkey (Türkiye) | Recruiting |
| Kutahya City Hospital | Kütahya, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06915597